Performant Healthcare, Inc. (PHLT)
(Delayed Data from NSDQ)
$7.64 USD
+4.09 (115.21%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $7.62 -0.02 (-0.26%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PHLT 7.64 +4.09(115.21%)
Will PHLT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PHLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHLT
Performant Healthcare (PHLT) Upgraded to Strong Buy: What Does It Mean for the Stock?
Organon (OGN) Q1 Earnings Surpass Estimates
PHLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
GoodRx Holdings, Inc. (GDRX) Q4 Earnings Match Estimates
Bausch + Lomb (BLCO) Surpasses Q4 Earnings and Revenue Estimates
Other News for PHLT
Performant Healthcare (PHLT) Downgraded Amid Acquisition Agreement
Crude Oil Down 2%; Amazon Shares Tumble After Q2 Results
Performant downgraded to Market Perform from Outperform at Citizens JMP
12 Health Care Stocks Moving In Friday's Intraday Session
Performant Healthcare (PHLT) Resumes Trading, Investor Focus Sharpens